Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
18.40B
Market cap18.40B
Price-Earnings ratio
23.71
Price-Earnings ratio23.71
Dividend yield
0.99%
Dividend yield0.99%
Average volume
1.87M
Average volume1.87M
High today
$97.11
High today$97.11
Low today
$95.15
Low today$95.15
Open price
$96.58
Open price$96.58
Volume
939.05K
Volume939.05K
52 Week high
$103.70
52 Week high$103.70
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

As of today, Zimmer Biomet(ZBH) shares are valued at $96.49. The company's market cap stands at 18.4B, with a P/E ratio of 23.71 and a dividend yield of 0.99%.

On 2026-10-27, Zimmer Biomet(ZBH) stock traded between a low of $95.15 and a high of $97.11. Shares are currently priced at $96.49, which is +1.4% above the low and -0.6% below the high.

Zimmer Biomet(ZBH) shares are trading with a volume of 939.05K, against a daily average of 1.87M.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $103.70 at its peak.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $103.70 at its peak.

ZBH News

Simply Wall St 3h
Could ROSA Knee Launch Alter The Investment Case For Zimmer Biomet Stock?

Zimmer Biomet Holdings reported several robotics milestones, including the past launch of ROSA Knee with OptimiZe in India, the extension of its TMINI partnersh...

TipRanks 5d
Zimmer Biomet’s recent weakness offers a buying opportunity, says Argus

Argus analyst David Toung keeps a Buy rating and $125 price target on Zimmer Biomet (ZBH) but believes that the stock’s recent weakness offers a buying opportun...

Analyst ratings

70%

of 30 ratings
Buy
26.7%
Hold
70%
Sell
3.3%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.